CD38通过CD45酸酶活性调节慢性淋巴细胞白血病的扩散
John F Imbery1,2, Celina Wiik1, Julia Heinzelbecker2,3
1Department of Immunology, Oslo University Hospital, Oslo, Norway.
Molecular therapy. Oncology
|October 30, 2024
概括
慢性淋巴细胞白血病 (CLL) 细胞生长受到CD38的调节,CD38控制B细胞受体 (BCR) 信号传递和通过CD45酸酶活性,CD43和加勒-1.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
背景情况:
- 慢性淋巴细胞白血病 (CLL) 的进展依赖于B细胞受体 (BCR) 信号和T辅助 (Th) 细胞相互作用.
- Th 细胞通过调节 CD45 酸酶活性通过 galectin-1 和 CD43.3 来增强 BCR 信号和增殖.
- CD38是CLL的负预后指标,与BCR信号传递和增殖有关,由Th细胞诱导.
研究的目的:
- 为了研究CD38和CD45酸酶活性调节在CLL之间的关系.
- 阐明CD38在通过微环境信号调节CLL增殖中的作用.
主要方法:
- 利用患者衍生的CLL细胞和Th细胞的共同培养模型.
- 在CLL细胞中分析了CD38,CD43和加勒-1的共同表达.
- 在 CD38 抑制后评估了 CD45 酸酶活性和 CLL 扩散.
- 采用了缺乏CD38或加勒-1的B细胞系来确认机械联系.
主要成果:
- 在具有高CD45活性的增殖性CLL细胞中,CD43和加勒-1与CD38共同表达.
- 抑制CD38影响了CD43和加勒-1表达,CD45活性和CLL增殖.
- 机理学研究证实了CD38介导的CD45活性和BCR信号通过CD43和galectin-1进行调节.
- 发现加勒-1有助于CD43/CD45的同位化.
结论:
- CD38是CD45酸酶活性的关键调节者,通过CD43和加勒-1.
- 这种CD38介导的途径积极调节CLL细胞增殖.
- CD38/CD45分子复合体是CLL治疗的潜在治疗点.
关键词:
在BCR信号传输中.CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38 CD38CD43 CD43 CD43 CD43 CD43 CD43 CD43 CD43 CD43 CD43 CD43 CD43 CD43 CD43CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45 CD45在 CLL CLL 中.MT: 定期发行 定期发行甲细胞是Th细胞.慢性淋巴细胞白血病 慢性淋巴细胞白血病盖莱克-1的使用情况它们的扩散和扩散.相关概念视频
Negative Regulator Molecules
35.2K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.2K
The Intrinsic Apoptotic Pathway
6.4K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.4K
Inhibition of Cdk Activity
4.7K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.7K
Receptor Downregulation in MVBs
2.0K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.0K


